BioCardia, Inc. (BCDA) Financials
BCDA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 4.8 million | 2.1 million |
| March 31, 2026 | 1.7 million | 2.8 million |
| Dec. 31, 2025 | 3.4 million | 2.5 million |
| Sept. 30, 2025 | 6.1 million | 3.5 million |
BCDA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.7 million | 109000 |
| March 31, 2026 | -1.7 million | 113000 |
| Dec. 31, 2025 | -2.5 million | 85000 |
| Sept. 30, 2025 | -1.7 million | 77000 |
BCDA Net Income
No data available :(
BCDA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 4.1 million | - | 293000 |
| March 31, 2026 | 951000 | - | 412000 |
| Dec. 31, 2025 | 2.5 million | - | 528000 |
| Sept. 30, 2025 | 5.3 million | - | 638000 |
BCDA Shares Outstanding
BCDA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 893000 | 730000 | - |
| March 31, 2026 | 3000 | 1.2 million | 1.0 million | - |
| Dec. 31, 2025 | 6000 | 1.1 million | 703000 | - |
| Sept. 30, 2025 | - | 932000 | 449000 | - |
BCDA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 124000 |
| March 31, 2026 | - | 124000 |
| Dec. 31, 2025 | - | 185000 |
| Sept. 30, 2025 | - | 107000 |
BCDA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BCDA
Price: $1.02
52 week price:
Earnings Per Share: -0.59 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 50500
Market Capitalization: 15.5 million